Non-interventional Prospective Observational Study of Cytoflavin in Combination With Reperfusion in Stroke Patients
Condition:   Acute Stroke Interventions:   Drug: Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin);   Drug: Control Sponsor:   POLYSAN Scientific& Technological Pharmaceutical Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2022 Category: Research Source Type: clinical trials

Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Condition:   Keratitis Interventions:   Combination Product: Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution;   Other: Standard of Care Therapy + Sham CXL + Artificial Tears Sponsor:   Peschke GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials